Global CDMO Leadership Catalent is a leading global CDMO offering end-to-end development and manufacturing across multiple modalities, with a proven track record of supporting FDA approvals and delivering programs at scale.

Patient Delivery Edge Their Zydis ODT technology provides a patient-centric delivery option that can differentiate products in adherence-critical indications and can be licensed or deployed across partner portfolios.

Gene Therapy Capabilities Catalent has active capabilities in gene therapy and late-phase AAV manufacturing, enabling tech transfer, GMP manufacturing, and regulatory support for sponsors pursuing viral vectors.

European Capacity Strategy A European footprint plus recent site decisions create nearshore capacity opportunities for EU sponsors seeking reliable, compliant supply across development to commercialization.

Trial Supply Network A broad global network supports clinical trial supply, packaging, labeling, and distribution, making Catalent a compelling partner for sponsors seeking end-to-end trial execution.